Outlook

Bill Ackman-Backed Nike Reports Worst Footwear Revenue In More Than A Decade, Takes Action To Continue 'Liquidating Inventory' Amid Grim Outlook
Microsoft Tightens Belt At McGill: 20GB OneDrive And Outlook Caps For Students On 'Security' And 'Sustainability' Grounds
Cathie Wood Outlines Role Of Bitcoin Post ETF Approval, Praises 21Shares: 'The Plumbing Works'
Microsoft Tightens Belt At McGill: 20GB OneDrive And Outlook Caps For Students On 'Security' And 'Sustainability' Grounds
Cathie Wood Outlines Role Of Bitcoin Post ETF Approval, Praises 21Shares: 'The Plumbing Works'
Global Economy Balances On Recovery Tightrope, Outlook Report Shows: 'This Is Hard'
High Tide's Second Quarter And Outlook: M&As And Organic Openings Coming Soon?

Outlook Recent News

OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says
On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,
Valens Company Q1 Revenue Increases 26% Sequentially To $18.5M
The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS), a leading manufacturer of cannabis products, reported its first-quarter fiscal year 2022 financial results late on Wednesday. Highlights
Analyst On Cresco's Deal With Columbia Care And Earnings Results For Q4 2021
The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00.
ScottsMiracle-Gro Reduces Sales Outlook For Hawthorne & Non-GAAP Adjusted EPS, Management Remains Optimistic
The Scotts Miracle-Gro Company (NYSE: SMG) has lowered its full-year sales guidance for its Hawthorne segment and said the reduction would likely lead to adjusted earnings per share that are lower than previously expected. What Happened?
Analyst On Green Thumb Industries: Impacted By Competition, Still A Top-Pick MSO
The Analyst: Pablo Zuanic, from Cantor Fitzgerald, kept an Overweight rating for Green Thumb Industries (OTCQX: GTBIF) (GTII.CN), and a price target at $41. The Thesis:
Brief Thoughts Ahead Of 4Q For Curaleaf Holdings: New Jersey Could Be Next Main Catalyst
The Analyst Pablo Zuanic, from Cantor Fitzgerald, kept Curaleaf (CSE:CURA) (OTCQX: CURLF) among the firm’s top picks in the MSO group, with an Overweight rating and a price target at US$16.50. The Thesis
Model Update For OrganiGram Holdings: 'Discount To Larger Peers Is Overdone'
Pablo Zuanic, analyst at  Cantor Fitzgerald, offered an updated investment model for OrganiGram (TSE: OGI) (NASDAQ: OGI) for which he maintained an Overweight but lowered the 12-month price target for the stock to C$5.30 from C$5.70, owing to the increased share count.
Tilray's Growth In Export Business 'Positively' Impresses Analyst, Maintains Overweight
In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an updated investment model for Tilray Inc. (NASDAQ: TLRY) in which he maintained an Overweight but lowered the price target for the stock to $6.90 from $7.40 on reduced estimates.</
This Week's Earnings Repertoire
With over 87% of S&P 500 companies already having beaten revenue and profit expectations, we're in for another round of Q2 corporate earnings, along with key jobs and inflation data.
Sponsored
August Outlook: Month's Highlights Include Key Earnings Reports, Fed's Jackson Hole Trip
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
Several Key Earnings Reports After The Close, Including Lululemon, Broadcom, Slack
The holding pattern continues to hold.  We’re seeing a bit of a selloff this morning, but it’s probably nothing to get too excited about considering how many days the market’s been up recently, and the fact that we have key jobs data tomorrow.
Wednesday's Market Minute: Either/Or, No More?
The stock market spent much of the past year divided along the lines of quarantine vs. recovery; the bifurcated trading experience that saw small-caps and mega-cap tech, or value and growth stocks, often moving in opposite directions.
Thursday's Market Minute: Bitcoin: Where To Watch
Cryptocurrency markets have been a bloodbath this week, with the reigning king bitcoin taking its fair share of the lumps. Generational-scale momentum trades can cut both ways, as the bitcoin futures contract tanked yesterday on massive volume and saw a decline of as much as -53% below its highs of scarcely more than a month ago on April 14.
Potential Double Profit With Bearish Sentiment
Hey 5-Star Trader,
Union Pacific, CSX Warn Of Coronavirus' Potential Impacts On Financial Returns
Citi Likes Microsoft's Purchase, But Not For $26 Billion
Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition
Moody's Lowers Outlook On Amazon To Negative, Affirms Debt At Baa1
Benzinga's Options Outlook for the Week of July 29: Earnings Leave Markets in Odd State
QBE Insurance Cuts 2011 Outlook
Deutsche Telekom Sticks To Outlook For Full Year
JinkoSolar Lowers Q3 Shipments, Revenue View
Gold Rallies to New Record High as Citigroup Raises Price Outlook
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved